New treatment options for castration-resistant prostate cancer.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Volumn 70, Issue 10, 2013, Pages 856-865

  Simondsen, Katherine ^a   Kolesar, Jill ^b  

^a University of Wisconsin Health   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABIRATERONE; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; CABAZITAXEL; CANCER VACCINE; SIPULEUCEL T; TAXOID; TISSUE EXTRACT;

CLINICAL TRIAL (TOPIC); FEE; HUMAN; MALE; ORCHIECTOMY; PROSTATE TUMOR; REVIEW;

ANDROSTENOLS; ANTINEOPLASTIC AGENTS; CANCER VACCINES; CLINICAL TRIALS AS TOPIC; FEES, PHARMACEUTICAL; HUMANS; MALE; ORCHIECTOMY; PROSTATIC NEOPLASMS; TAXOIDS; TISSUE EXTRACTS;

MLCS; MLOWN;

EID: 84886860400     PISSN: None     EISSN: 15352900     Source Type: None    
DOI: 10.2146/ajhp110586     Document Type: Review

References (0)